Trademarkia Logo

Australia

AU$
VIXVOSAN
Cancelled: Cancelled at the request of IB

Last updated on 4 Jan 2018

Owner Info

Sunesis Pharmaceuticals, Inc.

Suite 400

395 Oyster Point Blvd, UNITED STATES OF AMERICA

Serial Number

1591250 filed on 16 Oct 2013

Correspondent

Harold Milstein, Sheppard Mullin Richter & Hampton LLP

379 Lytton Avenue,

Palo Alto CA 94301,

UNITED STATES OF AMERICA

VIXVOSAN

Classification Information


Class [005]
Pharmaceutical preparations for the treatment of tumors, cancers, hematological disorders and hematological malignancies

Mark Details


Serial Number

1591250

Registered On

16 Oct 2013

Renewal On

NA

Mark Type

WORD

Priority Claim (Convention Details)


Date

19 Apr 2013

Mark Type

US

Legal History


Show more

Status DateAction Taken
4th Jan 2018Cancellation of Entry in Register Published
21st Dec 2017Cancel IP Right
21st Sept 2017General Correspondence (Application or Registration)
20th Feb 2014IP Right Registration Published
13th Feb 2014Register Trade Mark
13th Feb 2014Application Status
5th Dec 2013IP Right Acceptance Published
28th Nov 2013Clear Examination report approved
28th Nov 2013Application Accepted correspondence sent
21st Nov 2013IP Right Filed Published